产品名称
抗-磷酸化-Trk B (pTyr515) 兔抗, affinity isolated antibody
biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
antigen 91 kDa
species reactivity
human, rat, mouse
concentration
~1 mg/mL
technique(s)
ELISA: 1:5000
immunohistochemistry: 1:50-1:100
western blot: 1:500-1:1000
NCBI accession no.
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
phosphorylation (pTyr515)
Quality Level
Gene Information
human ... NTRK2(4915)
Biochem/physiol Actions
神经营养性酪氨酸激酶受体2型(NTRK2)可在神经母细胞瘤(NB)中，调控良好和不良的临床作用。还能在杏仁核中，调节谷氨酸受体和突触可塑性作用。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Features and Benefits
完全放心地使用我们的抗体。如果抗体在您的申请的研究中不起作用，我们将全额退款或安排替代抗体。了解更多信息。
General description
神经营养性酪氨酸激酶受体2型(NTRK2)又称为原肌球蛋白受体激酶B(TRKB)。属于神经营养因子受体Trk家族。位于人类染色体9q21.32。
Immunogen
抗血清由人Trk B中围绕Tyr525磷酸化位点的一段序列对应的合成肽免疫生产。
免疫原范围： 481-530
免疫原范围： 481-530
Physical form
兔IgG，溶于磷酸盐缓冲液（不含Mg2+和Ca2+），pH 7.4,150mM NaCl，0.02％叠氮化钠和50％甘油中。
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
常规特殊物品
此项目有
Micaela Lucarelli et al.
Molecular neurobiology, 60(9), 5395-5410 (2023-06-14)
Niemann-Pick type C1 (NPC1) disease is a lysosomal lipid storage disorder due to mutations in the NPC1 gene resulting in the accumulation of cholesterol within the endosomal/lysosomal compartments. The prominent feature of the disorder is the progressive Purkinje cell degeneration
Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma.
Diamandis P, et al.
Diagnostic Pathology, 11(1), 13-13 (2016)
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model
Iyer R, et al.
Cancer Letters, 372(2), 179-186 (2016)
Yan Liu et al.
Neuropharmacology, 144, 337-344 (2018-11-09)
NSI-189 Phosphate, (4-benzylpiperazin-1-yl)-[2-(3-methyl-butylamino)pyridin-3-yl] methanone is a new chemical entity under development for the treatment of MDD, based upon preclinical data demonstrating stimulation of neurogenesis of human hippocampus-derived neural stem cells in vitro and in mouse hippocampus in vivo. Previous studies
A common NTRK2 variant is associated with emotional arousal and brain white-matter integrity in healthy young subjects.
Spalek K, et al.
Translational Psychiatry, 6(3), e758-e758 (2017)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持